Dual targeting of DDX3 and eIF4A by the translation inhibitor rocaglamide A
{{output}}
The translation inhibitor rocaglamide A (RocA) has shown promising antitumor activity because it uniquely clamps eukaryotic initiation factor (eIF) 4A onto polypurine RNA for selective translational repression. As eIF4A has been speculated to be a unique targe... ...
